356 related articles for article (PubMed ID: 36699095)
1. A novel strategy for bioactive natural products targeting NLRP3 inflammasome in Alzheimer's disease.
Yang Z; Liu J; Wei S; Deng J; Feng X; Liu S; Liu M
Front Pharmacol; 2022; 13():1077222. PubMed ID: 36699095
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of NLRP3 Inflammasome Activation: Its Role in the Treatment of Alzheimer's Disease.
Zhang Y; Zhao Y; Zhang J; Yang G
Neurochem Res; 2020 Nov; 45(11):2560-2572. PubMed ID: 32929691
[TBL] [Abstract][Full Text] [Related]
3. The Role of NLRP3 Inflammasome in Alzheimer's Disease and Potential Therapeutic Targets.
Liang T; Zhang Y; Wu S; Chen Q; Wang L
Front Pharmacol; 2022; 13():845185. PubMed ID: 35250595
[TBL] [Abstract][Full Text] [Related]
4. The involvement of NLRP3 inflammasome in the treatment of Alzheimer's disease.
Feng YS; Tan ZX; Wu LY; Dong F; Zhang F
Ageing Res Rev; 2020 Dec; 64():101192. PubMed ID: 33059089
[TBL] [Abstract][Full Text] [Related]
5. Soluble Aβ oligomers and protofibrils induce NLRP3 inflammasome activation in microglia.
Lučiūnaitė A; McManus RM; Jankunec M; Rácz I; Dansokho C; Dalgėdienė I; Schwartz S; Brosseron F; Heneka MT
J Neurochem; 2020 Dec; 155(6):650-661. PubMed ID: 31872431
[TBL] [Abstract][Full Text] [Related]
6. The Role of Microglia and the Nlrp3 Inflammasome in Alzheimer's Disease.
Hanslik KL; Ulland TK
Front Neurol; 2020; 11():570711. PubMed ID: 33071950
[TBL] [Abstract][Full Text] [Related]
7. Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo.
Stancu IC; Cremers N; Vanrusselt H; Couturier J; Vanoosthuyse A; Kessels S; Lodder C; Brône B; Huaux F; Octave JN; Terwel D; Dewachter I
Acta Neuropathol; 2019 Apr; 137(4):599-617. PubMed ID: 30721409
[TBL] [Abstract][Full Text] [Related]
8. Targeting NLRP3-Mediated Neuroinflammation in Alzheimer's Disease Treatment.
Barczuk J; Siwecka N; Lusa W; Rozpędek-Kamińska W; Kucharska E; Majsterek I
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012243
[TBL] [Abstract][Full Text] [Related]
9. Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer's Disease Brain.
Ahmed ME; Iyer S; Thangavel R; Kempuraj D; Selvakumar GP; Raikwar SP; Zaheer S; Zaheer A
J Alzheimers Dis; 2017; 60(3):1143-1160. PubMed ID: 28984607
[TBL] [Abstract][Full Text] [Related]
10. Beta-amyloid activates NLRP3 inflammasome via TLR4 in mouse microglia.
Liu Y; Dai Y; Li Q; Chen C; Chen H; Song Y; Hua F; Zhang Z
Neurosci Lett; 2020 Sep; 736():135279. PubMed ID: 32726591
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic and therapeutic role of NLRP3 inflammasome in the pathogenesis of Alzheimer's disease.
Jha D; Bakker ENTP; Kumar R
J Neurochem; 2023 Feb; ():. PubMed ID: 36802053
[TBL] [Abstract][Full Text] [Related]
12. NLRP3 Inflammasome: A Starring Role in Amyloid-β- and Tau-Driven Pathological Events in Alzheimer's Disease.
Van Zeller M; Dias D; Sebastião AM; Valente CA
J Alzheimers Dis; 2021; 83(3):939-961. PubMed ID: 34366341
[TBL] [Abstract][Full Text] [Related]
13. A Novel Inhibitor Targeting NLRP3 Inflammasome Reduces Neuropathology and Improves Cognitive Function in Alzheimer's Disease Transgenic Mice.
Kuwar R; Rolfe A; Di L; Blevins H; Xu Y; Sun X; Bloom GS; Zhang S; Sun D
J Alzheimers Dis; 2021; 82(4):1769-1783. PubMed ID: 34219728
[TBL] [Abstract][Full Text] [Related]
14. [Nucleotide-binding Oligomerization Domain-like Receptor Family Pyrin Domain Containing 3 Inflammasome in Alzheimer's Disease].
Feng YY; Chen H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Oct; 43(5):788-795. PubMed ID: 34728041
[TBL] [Abstract][Full Text] [Related]
15. Identification of inflammasome signaling proteins in neurons and microglia in early and intermediate stages of Alzheimer's disease.
Vontell RT; de Rivero Vaccari JP; Sun X; Gultekin SH; Bramlett HM; Dietrich WD; Keane RW
Brain Pathol; 2023 Jul; 33(4):e13142. PubMed ID: 36579934
[TBL] [Abstract][Full Text] [Related]
16. Glycogen Synthase Kinase-3β, NLRP3 Inflammasome, and Alzheimer's Disease.
Jia YR; Guo ZQ; Guo Q; Wang XC
Curr Med Sci; 2023 Oct; 43(5):847-854. PubMed ID: 37721665
[TBL] [Abstract][Full Text] [Related]
17. α1-antitrypsin mitigates NLRP3-inflammasome activation in amyloid β
Ebrahimi T; Rust M; Kaiser SN; Slowik A; Beyer C; Koczulla AR; Schulz JB; Habib P; Bach JP
J Neuroinflammation; 2018 Sep; 15(1):282. PubMed ID: 30261895
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's Disease: New Concepts on the Role of Autoimmunity and NLRP3 Inflammasome in the Pathogenesis of the Disease.
Severini C; Barbato C; Di Certo MG; Gabanella F; Petrella C; Di Stadio A; de Vincentiis M; Polimeni A; Ralli M; Greco A
Curr Neuropharmacol; 2021; 19(4):498-512. PubMed ID: 32564756
[TBL] [Abstract][Full Text] [Related]
19. Microglial TLR4/NLRP3 Inflammasome Signaling in Alzheimer's Disease.
Li Y; Chen X; Zhou M; Feng S; Peng X; Wang Y
J Alzheimers Dis; 2024; 97(1):75-88. PubMed ID: 38043010
[TBL] [Abstract][Full Text] [Related]
20. TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease.
Yang J; Wise L; Fukuchi KI
Front Immunol; 2020; 11():724. PubMed ID: 32391019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]